View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
July 11, 2019updated 17 Feb 2022 4:20am

Hillrom to offload surgical consumable products for $170m

Medical technology company Hillrom has agreed to divest select surgical consumable products and related assets to an Audax Private Equity affiliate for $170m.

Medical technology company Hillrom has agreed to divest select surgical consumable products and related assets to an Audax Private Equity affiliate for $170m.

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

The surgical consumable products include Bard-Parker conventional and safety scalpels and blades, along with additional operating room accessories.

The approximately 500 employees who support these products will be retained after the completion of the deal. Hillrom employs a total of around 10,000 people.

The surgical products being sold are expected to produce nearly $100m in annual revenue and contribute approximately $0.20 in adjusted earnings per diluted share on a pro forma basis for fiscal 2019.

Hillrom expects the divestiture to allow better focus on other categories across its portfolio.

Hillrom president and CEO John Groetelaars said: “The sale of these surgical products will strengthen our ability to focus our resources across our portfolio as we continue to build a differentiated suite of connected solutions for patients and caregivers.

“This transaction underscores our strategic focus on high-growth, high-margin categories where Hillrom can demonstrate leadership and supports our commitment to deliver on our promise of advancing connected care.”

The company develops solutions for earlier diagnosis and treatment, aiming to optimise surgical efficiency and speed-up patient recovery, and simplify clinical communication and care.

Its portfolio includes connected smart beds, patient lifts, assessment and monitoring technologies, caregiver communication tools, respiratory care devices and operating room equipment.

The divested products are part of the company’s Surgical Workflow and Positioning line and fall under the Surgical Access category. The line also comprises surgical and examination lights, gyn/uro/lap products, surgical tables, orthopaedic and spine products.

Related Companies

Free Report
img

Find the right pricing strategy for your medical device

How do your competitors set prices in different markets? Will reducing your prices win market share from your main competitors? Do you need to position products differently for different markets? To find out, use our Global Brand Pricing tool to achieve optimal pricing for your devices. Detect price changes, understand competitor market positioning, and plan new product launches, by accessing this tool today. It features:
  • A proprietary algorithm that leverages numerous pricing sources, with an emphasis on real-world data
  • Estimates of the likely spread of selling prices per brand and manufacturer, as well as 3-year forecasts for prices
  • Medical device pricing data that can be tracked by market, company, and brand
  • Additional categories that can be built on a custom basis
Use our tool to access competitor pricing strategies across multiple geographies, and various dynamic case studies from the likes of Germany and China, to benchmark yourself against your competitors and future proof your pricing strategies.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network